Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,135 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04393701Recruiting
Testing newborn blood spots to check for rare storage diseases
This pilot study tries a systematic way to look for several rare “lysosomal storage” diseases in newborns using a specialized lab test on routine blood samples. It may help detect these conditions earlier so treatment can start sooner if needed.
CaenAges 1 day–4 days - NCT04451915Recruiting
Study for early gestational diabetes in pregnancy
This study is looking at pregnant people who have early signs of gestational diabetes in the first half of pregnancy. It may help find safer ways to monitor or treat early diabetes-related blood sugar changes to improve pregnancy outcomes.
ArrasAges 18 years+ - NCT04391335Recruiting
Breathing tests to spot lung scarring after stem cell transplant
This study checks new ways to measure breathing in children who had a stem cell transplant to better detect a lung condition called bronchiolitis obliterans syndrome. If you join, you’ll do breathing and imaging tests, and researchers will look for patterns that may help with diagnosis.
Toronto, OntarioAges 6–18 - NCT04445584Recruiting
7-Tesla MRI study of the spine in people with no symptoms
This study uses a very strong MRI scanner to look at the spine’s fine details. It may help researchers better understand normal spine anatomy and how it appears in people with chronic back pain.
Zurich, Canton of ZurichAges 18 years+ - NCT04446273Recruiting
Robotic therapy timing to improve arm movement after stroke
This trial studies whether giving robotic therapy to the shoulder and arm in a “priority” way (instead of focusing on the hand first) helps improve arm movement in people with chronic stroke. It may help by improving how your arm muscles and joints are trained to work together.
Taipei, TaipeiAges 20–75 - NCT04400266RecruitingPhase 4
Buspirone and melatonin for depression after a brain injury
This trial studies whether the medicines buspirone and melatonin can reduce depression symptoms in people who had a mild or moderate traumatic brain injury (TBI) at least 3 months ago. It may help if you have ongoing depression after TBI and can safely take study medications and attend regular visits, including MRI scans.
Boston, MassachusettsAges 18–64 - NCT04482478Recruiting
Edl treatment trial for functional indigestion symptoms
This trial studies whether EDL medicine can improve symptoms of functional dyspepsia (indigestion) and is safe for people with this condition. You may be asked to complete symptom questionnaires and undergo stomach testing to confirm there is no other cause for your symptoms.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT04180085RecruitingPhase 2
Belatacept to protect kidneys in heart transplant patients
This trial studies whether belatacept can be used after a heart transplant to help protect kidney function over time. It focuses on people who already have (or are at risk for) worsening kidney function after transplant, while avoiding those with certain infections or rejection concerns.
BordeauxAges 18 years+ - NCT04319627RecruitingPhase 3
Statins to prevent new blood clots after leg clot or lung clot
This trial tests whether taking a statin (rosuvastatin) after a recent leg blood clot (DVT) and/or lung blood clot (PE) can lower the chance of future venous clots. You might benefit if you’re at risk for more clotting and can take the study medication safely.
Calgary, AlbertaAges 18 years+ - NCT02714764Recruiting
Testing how best to measure outcomes in Alexander disease
This study is looking at which measurements best capture changes over time in people with Alexander disease. It may help researchers and doctors track the disease more accurately in future care and studies.
Philadelphia, PennsylvaniaAges Any age - NCT04288635Recruiting
Testing a nutrient supplement for energy problems in septic shock
This study looks at whether a metabolite (nutrient) supplement can help the body’s cells work better when someone is in septic shock. It is done in the ICU, and it may benefit people with sepsis who still have poor circulation and high lactate levels despite standard treatment.
Angers, Maine et LoireAges 18 years+ - NCT04370574Recruiting
Testing blood or tissue markers for suspected pancreatic cancer
This trial looks for “soluble biomarkers” (markers that can be found in body fluids like blood) for people who have a pancreatic mass and may have pancreatic ductal adenocarcinoma. The goal is to improve how pancreatic cancer is identified, especially using information taken from an endoscopic ultrasound biopsy.
Montpellier, MontpellierAges 18 years+ - NCT04265703Recruiting
Ultrasound-guided line placement for hard-to-access veins
This study tests a specific ultrasound-guided technique to place a central venous catheter (a medical access line) when jugular veins are difficult to access. It may help reduce failed attempts and improve safety in people who need this kind of line for medical care.
GuadalajaraAges 18–80 - NCT04289467RecruitingPhase 2
Fenfluramine for stubborn infantile spasms
This Phase 2 trial studies fenfluramine to treat infantile spasms that haven’t improved after standard medicines (ACTH and vigabatrin). If you/your child has ongoing seizures, the study may offer another treatment option and will monitor safety closely, especially heart-related side effects.
Los Angeles, CaliforniaAges 1–3 - NCT04348318Recruiting
Evaluating an advance care plan for ICU patients
This study looks at how well advance care planning documents are put into action for people who stay in the intensive care unit (ICU). If you participated, it may help the hospital improve how patients’ wishes are followed during serious illness.
AarauAges 18 years+ - NCT04323371Recruiting
Study testing for heart-shock to reduce future events
This trial studies how to identify different types of “cardiogenic shock,” a serious drop in heart blood flow. It aims to use detailed patient information to guide care and possibly lower the chance of dangerous outcomes.
MilanAges 18–74 - NCT04284943Recruiting
Surgery for stomach cancer and diabetes
This trial tests a surgery for early-stage stomach cancer that also aims to improve type 2 diabetes by changing how your body processes food. It might be an option if you have both conditions and are not using insulin.
SeoulAges 20–69 - NCT04356469RecruitingPhase 2
Donor stem cell transplant for serious blood disorders in children
This trial tests a special type of donor stem cell transplant (with donor T-cells removed) to treat serious non-cancer blood problems in children. It may help by resetting the bone marrow so the body can make healthy blood cells again.
St. Petersburg, FloridaAges birth–21 years - NCT04318678RecruitingPhase 1
CD123 CAR T-cell therapy for relapsed leukemia and related cancers
This early-phase study tests a lab-made immune therapy (CD123 CAR T cells) for children and young adults up to age 21 whose cancer has come back or didn’t respond to treatment. The goal is to see if these CAR T cells can find and attack cancer cells that carry a marker called CD123.
Memphis, TennesseeAges Up to 21 years - NCT04297085Recruiting
Study of why blood clots in veins come back
This study follows people who have had a vein blood clot (or related venous clot) to understand what factors may make the clot happen again. It may help clinicians find better ways to prevent repeat clots.
BrestAges Any age - NCT04295252Recruiting
Altshock-2 registry for people with cardiogenic shock
This study is a “registry,” meaning it collects health information from people hospitalized with cardiogenic shock. It may help doctors better understand the condition and improve care over time.
MilanAges 18 years+ - NCT04330118Recruiting
Study immune cells in DRESS and drug rash reactions
This trial studies how certain immune cells (eosinophils) behave during severe drug reactions like DRESS and during milder drug rashes. It may help doctors understand what drives organ damage and improve how these reactions are managed.
ArrasAges 18 years+ - NCT04368663Recruiting
TJ-134 for bowel cysts causing symptoms
This trial looks at whether TJ-134, a traditional herbal medicine, helps people who have symptomatic pneumatosis cystoides intestinalis (bowel cysts). It may help reduce symptoms if the condition matches the typical colonoscopy findings.
Komagane, NaganoAges 18–100 - NCT04286308Recruiting
Testing brain-speech recordings during DBS for movement disorders
This study looks at how brain and speech networks work while people with Parkinson’s disease, essential tremor, or dystonia are getting deep brain stimulation (DBS). It may help doctors better understand and possibly improve speech outcomes for people receiving DBS.
Boston, MassachusettsAges 18–85
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,135 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.